First Advantage $439.9 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Century Therapeutics $242.7 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Codere Online business combination with DD3 Acquisition Corp. II
We are advising Codere Online on its combination with a SPAC
Jamf $281 million follow-on offering
We advised the underwriters on the SEC-registered stock offering
TaskUs $303.6 million IPO
We advised the underwriters on the IPO and Nasdaq listing
ImmunityBio $500 million at-the-market offering
We advised the sales agent in connection with the equity offering
UiPath $1.54 billion IPO
The shares are listed on the New York Stock Exchange
Americo Life $400 million senior notes offering
We advised the initial purchasers on the investment-grade notes offering
Maravai LifeSciences $646.9 million secondary offering
We advised the joint book-running managers on the equity offering
Nuvei $494 million secondary offering
We advised Nuvei on its secondary offering of subordinate voting shares on a bought deal basis